Evaluating your likely current (and near future) state of health means taking into account the risk factors — such as aspirin use — that affect you. Our medical diagnosis tool, The Analyst™, identifies major risk factors by asking the right questions.
How often do you use aspirin?
Possible responses:→ Don't know
→ Never / less that once a year
→ Occasionally / only when I need it
→ Regularly - several times a month
→ Often - daily or almost daily
Aspirin thins the blood and can increase bleeding.
Inflammation may be caused by aspirin and nonsteroidal anti-inflammatory medications (NSAIDs), but the bacterium H. pylori is generally responsible.
Aspirin may damage the lining of the stomach, but it is believed that the bacterium H. pylori is usually the cause.
A study published in October 2011 and involving 4,000 elderly participants across Europe found that those who took aspirin every day were twice as likely to be diagnosed with late stage age-related age-related macular degeneration (AMD) as those who did not.
During another major study at the Netherlands Institute for Neuroscience and Academic Medical Centre, researchers followed 839 people and found that among those who took aspirin each day, around 4% had an advanced form of the disease called neovascular or 'wet' AMD, which leads to the most profound blindness. In comparison, just 2% who took aspirin less frequently had the same disease.
A more conclusive Australian study was published January 2013 in the Journal of the American Medical Association (JAMA) and followed 2,400 subjects for 15 years. It found that 3.7% of the 'occasional' users of aspirin and 9.4% of the 'regular' users developed wet AMD.
However, for those suffering from heart disease, the benefits of taking aspirin outweigh the risks posed to their vision.
People who regularly take aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) have a reduced risk of developing Alzheimer's Disease.
Aspirin may slightly reduce risk of estrogen receptor positive forms of breast cancer.
Several studies have demonstrated reduced mortality from various cancers among regular aspirin users. A 2012 study showed a large reduction in death from esophageal, stomach and colon cancers among daily aspirin users, and a 12% reduction for other types of cancer. [JNCI J Natl Cancer Inst (2012) 104 (16): pp1208-1217]
A study published on November 28th, 2012 in the Journal of the National Cancer Institute showed that those who used aspirin saw a 45% reduction in the risk of death from chronic liver disease. The study followed 300,000 people aged between 51 and 70 for between 10 and 12 years. Those who took other types of NSAIDs had a 26% lower chance of dying from chronic liver disease, but had no corresponding reduction in the risk of liver cancer.
Aspirin has been found to reduce the risk of colorectal cancer by up to 60%, with researchers finding that 600mg of aspirin per day for 25 months substantially reduces cancer incidence after 5 years in carriers of hereditary colorectal cancer.
A November 2012 study published in the New England Journal of Medicine showed a 34% reduction in the risk of death associated with heart attack among patients who used aspirin daily.
Several studies have noted a reduction in the risk of esophageal, gastric and biliary cancers among regular aspirin users. A 2012 study showed that those who used aspirin daily had a 40% lower risk of death from esophageal cancer. [JNCI J Natl Cancer Inst (2012) 104 (16): pp1208-1217]
A study published on November 28th, 2012 in the Journal of the National Cancer Institute showed that those who used aspirin to treat pain saw a 41% reduction in their risk of developing liver cancer. However, the incidence of liver cancer in the general population is already very low, so the risks from aspirin far outweigh the potential benefits in those who are not at increased risk of liver cancer or liver disease.
Several studies have noted a reduction in the risk of esophageal, gastric and biliary cancers among regular aspirin users. A 2012 study showed that those who used aspirin daily had a 40% lower risk of death from stomach cancer. [JNCI J Natl Cancer Inst (2012) 104 (16): pp1208-1217]